 | Up a level |
Afferi, Luca; Spahn, Martin; Hayoz, Stefanie; Strebel, Räto T; Rothschild, Sacha I; Seifert, Helge; Özdemir, Berna C; Kiss, Bernhard; Maletzki, Philipp; Engeler, Daniel; Wirth, Gregory; Hadaschik, Boris; Lucca, Ilaria; John, Hubert; Sauer, Andreas; Müntener, Michael; Bubendorf, Lukas; Schneider, Martina; Musilova, Jana; Petrausch, Ulf; ... (2024). Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine. BJU international, 134(3), pp. 388-397. Wiley 10.1111/bju.16318
Templeton, Arnoud J; Omlin, Aurelius; Berthold, Dominik; Beyer, Jörg; Burger, Irene A; Eberli, Daniel; Engeler, Daniel; Fankhauser, Christian; Fischer, Stefanie; Gillessen, Silke; Nicolas, Guillaume; Kroeze, Stephanie; Lorch, Anja; Müntener, Michael; Papachristofilou, Alexandros; Schaefer, Niklaus; Seiler, Daniel; Stenner, Frank; Tsantoulis, Petros; Vlajnic, Tatjana; ... (2023). Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. Swiss medical weekly, 153, p. 40108. EMH Schweizerischer Ärzteverlag 10.57187/smw.2023.40108
Viktorin-Baier, Pascal; Putora, Paul M.; Schmid, Hans-Peter; Plasswilm, Ludwig; Schwab, Christoph; Thoeni, Armin; Hochreiter, Werner; Prikler, Ladislav; Suter, Stefan; Stucki, Patrick; Müntener, Michael; Blick, Nadja; Schiefer, Hans; Güsewell, Sabine; Zürn, Karin; Engeler, Daniel (2020). Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry. BJU international, 125(6), pp. 827-835. Wiley 10.1111/bju.15003
Cathomas, Richard; Schmid, Hans-Peter; Aebersold, Daniel; Amram, Marie-Laure; Berthold, Dominik; Eberli, Daniel; Gillessen, Silke; Iselin, Christophe; Jichlinski, Patrice; Müntener, Michael; Rentsch, Cyrill; Schäfer, Niklaus; Stenner, Frank; Thalmann, George; Wild, Peter; Wyler, Stephen; Omlin, Aurelius Gabriel (2016). Medikamentöse Behandlung des metastasierten Prostatakarzinoms. Swiss Medical Forum, 16(11), pp. 266-272. EMH Swiss Medical Publishers
Montani, Matteo; Hermanns, Thomas; Müntener, Michael; Wild, Peter; Sulser, Tullio; Kristiansen, Glen (2013). Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Archiv, 462(4), pp. 437-443. Springer 10.1007/s00428-013-1390-8
Gerhardt, Josefine; Montani, Matteo; Wild, Peter; Beer, Marc; Huber, Fabian; Hermanns, Thomas; Müntener, Michael; Kristiansen, Glen (2012). FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer. American journal of pathology, 180(2), pp. 848-61. New York, N.Y.: Elsevier 10.1016/j.ajpath.2011.10.021
Beer, Marc; Montani, Matteo; Gerhardt, Josefine; Wild, Peter J; Hany, Thomas F; Hermanns, Thomas; Müntener, Michael; Kristiansen, Glen (2012). Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates. Prostate, 72(3), pp. 318-25. Hoboken, N.J.: Wiley-Blackwell 10.1002/pros.21434
